70 related articles for article (PubMed ID: 33755903)
1. Genome Editing Using Cas9-gRNA Ribonucleoprotein in Human Pluripotent Stem Cells for Disease Modeling.
Benetó N; Grinberg D; Vilageliu L; Canals I
Methods Mol Biol; 2022; 2549():409-425. PubMed ID: 33755903
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
Elife; 2022 Sep; 11():. PubMed ID: 36069759
[TBL] [Abstract][Full Text] [Related]
3. Cationic lipid nanoparticle-mediated delivery of a Cas9/crRNA ribonucleoprotein complex for transgene-free editing of the citrus plant genome.
Mahmoud LM; Dutt M
Plant Cell Rep; 2024 Jun; 43(7):171. PubMed ID: 38874819
[TBL] [Abstract][Full Text] [Related]
4. CRISPRi/a Screening with Human iPSCs.
Nishiga M; Qi LS; Wu JC
Methods Mol Biol; 2021; 2320():261-281. PubMed ID: 34302664
[TBL] [Abstract][Full Text] [Related]
5. CRISPRoff enables spatio-temporal control of CRISPR editing.
Carlson-Stevermer J; Kelso R; Kadina A; Joshi S; Rossi N; Walker J; Stoner R; Maures T
Nat Commun; 2020 Oct; 11(1):5041. PubMed ID: 33028827
[TBL] [Abstract][Full Text] [Related]
6. OliTag-seq enhances in cellulo detection of CRISPR-Cas9 off-targets.
Yang ZX; Deng DH; Gao ZY; Zhang ZK; Fu YW; Wen W; Zhang F; Li X; Li HY; Zhang JP; Zhang XB
Commun Biol; 2024 Jun; 7(1):696. PubMed ID: 38844522
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 editing of synaptic genes in human embryonic stem cells for functional analysis in induced human neurons.
Houcek A; Ma ZZ; Trauterman B; Uzay B; Monteggia LM; Kavalali ET
STAR Protoc; 2024 Jun; 5(2):103089. PubMed ID: 38795356
[TBL] [Abstract][Full Text] [Related]
8. Streptococcus pyogenes Cas9 ribonucleoprotein delivery for efficient, rapid and marker-free gene editing in Trypanosoma and Leishmania.
Asencio C; Hervé P; Morand P; Oliveres Q; Morel CA; Prouzet-Mauleon V; Biran M; Monic S; Bonhivers M; Robinson DR; Ouellette M; Rivière L; Bringaud F; Tetaud E
Mol Microbiol; 2024 Jun; 121(6):1079-1094. PubMed ID: 38558208
[TBL] [Abstract][Full Text] [Related]
9. Optical Genome Mapping Reveals Genomic Alterations upon Gene Editing in hiPSCs: Implications for Neural Tissue Differentiation and Brain Organoid Research.
Gallego Villarejo L; Gerding WM; Bachmann L; Hardt LHI; Bormann S; Nguyen HP; Müller T
Cells; 2024 Mar; 13(6):. PubMed ID: 38534351
[TBL] [Abstract][Full Text] [Related]
10. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
11. Generation of homozygous and heterozygous REEP1 knockout induced pluripotent stem cell lines by CRISPR/Cas9 gene editing.
Korneck M; Leonhardt A; Schöls L; Hauser S
Stem Cell Res; 2024 Jun; 77():103378. PubMed ID: 38479332
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated editing of ACTB in induced pluripotent stem cells: A model for investigating human ACTB loss-of-function and genetic adaptive responses.
Binder S; Ramachandran H; Haslinger D; Hildebrandt B; Dobner J; Haarmann-Stemmann T; Chiocchetti A; Rossi A
Stem Cell Res; 2024 Jun; 77():103395. PubMed ID: 38518401
[TBL] [Abstract][Full Text] [Related]
13. Protocol for scarless genome editing of human pluripotent stem cell based on orthogonal selective reporters.
Zhao Y; Pan Z; Hong Z; Sun M; Hong Y; Peng X; Li X; Wang X; Wang K
STAR Protoc; 2024 Jun; 5(2):103084. PubMed ID: 38787727
[TBL] [Abstract][Full Text] [Related]
14. MAGIK: A rapid and efficient method to create lineage-specific reporters in human pluripotent stem cells.
Haideri T; Lin J; Bao X; Lian XL
Stem Cell Reports; 2024 May; 19(5):744-757. PubMed ID: 38579711
[TBL] [Abstract][Full Text] [Related]
15. Near-perfect precise on-target editing of human hematopoietic stem and progenitor cells.
Cloarec-Ung FM; Beaulieu J; Suthananthan A; Lehnertz B; Sauvageau G; Sheppard HM; Knapp DJHF
Elife; 2024 Jun; 12():. PubMed ID: 38829685
[TBL] [Abstract][Full Text] [Related]
16. Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.
Darle A; Mahiet T; Aubin D; Doyen M; El Kassar L; Parfait B; Lemaitre G; Baldeschi C; Allouche J; Holic N
Front Cell Dev Biol; 2024; 12():1359561. PubMed ID: 38481529
[TBL] [Abstract][Full Text] [Related]
17. Strategies of Bladder Reconstruction after Partial or Radical Cystectomy for Bladder Cancer.
Zeng XX; Wu Y
Mol Biotechnol; 2024 May; ():. PubMed ID: 38761327
[TBL] [Abstract][Full Text] [Related]
18. Correction: Current Strategies of Modeling Human Trophoblast Using Human Pluripotent Stem Cells in vitro.
Cheung VC; Bui T; Soncin F; Bai T; Kessler JA; Parast MM; Horii M
Curr Protoc; 2024 Apr; 4(4):e1049. PubMed ID: 38648076
[No Abstract] [Full Text] [Related]
19. Correction to: Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells.
Protein Cell; 2024 May; 15(5):393. PubMed ID: 38113127
[No Abstract] [Full Text] [Related]
20. CRISPR/Cas9-Mediated Introduction of Specific Heterozygous Mutations in Human Induced Pluripotent Stem Cells.
Brandão KO; Grandela C; Yiangou L; Mummery CL; Davis RP
Methods Mol Biol; 2022; 2454():531-557. PubMed ID: 33755904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
